Effect of targeted agents on the endocrine response of breast cancer in the neoadjuvant setting: a systematic review.

about

Integrative meta-analysis identifies microRNA-regulated networks in infantile hemangioma E-cadherin loss induces targetable autocrine activation of growth factor signalling in lobular breast cancer

P2860

Q29248288-9E4DEC43-90EF-46C9-A1FE-4285665EFDAB Q58603744-48B8C0E2-4FBF-4346-8B2E-9EF81AFDDD9B

P2860

Effect of targeted agents on the endocrine response of breast cancer in the neoadjuvant setting: a systematic review.

Item

http://www.wikidata.org/entity/Q35631641

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Effect of targeted agents on t ...... setting: a systematic review.

@ast

Effect of targeted agents on t ...... setting: a systematic review.

@en

type

Item

label

Effect of targeted agents on t ...... setting: a systematic review.

@ast

Effect of targeted agents on t ...... setting: a systematic review.

@en

prefLabel

Effect of targeted agents on t ...... setting: a systematic review.

@ast

Effect of targeted agents on t ...... setting: a systematic review.

@en

P1476

Effect of targeted agents on t ...... setting: a systematic review.

@en

P2093

Antonino Grassadonia

http://www.w3.org/2001/XMLSchema#string

Marinella Zilli

http://www.w3.org/2001/XMLSchema#string

Marta Caporale

http://www.w3.org/2001/XMLSchema#string

Michele DeTursi

http://www.w3.org/2001/XMLSchema#string

Nicola Tinari

http://www.w3.org/2001/XMLSchema#string

Patrizia Vici

http://www.w3.org/2001/XMLSchema#string

Teresa Gamucci

http://www.w3.org/2001/XMLSchema#string

P2860

Overexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progression

Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancer

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer

Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial.

Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer.

The relevance of breast cancer subtypes in the outcome of neoadjuvant chemotherapy.

Neoadjuvant chemotherapy for operable breast cancer.

Vascular endothelial growth factor reduces tamoxifen efficacy and promotes metastatic colonization and desmoplasia in breast tumors

Pilot trial of preoperative (neoadjuvant) letrozole in combination with bevacizumab in postmenopausal women with newly diagnosed estrogen receptor- or progesterone receptor-positive breast cancer.

A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer.

P304

575-582

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/JCA.11566

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Clara Natoli

P577

2015-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277080256

http://www.w3.org/2001/XMLSchema#string

P698

26000050

http://www.w3.org/2001/XMLSchema#string

P932

4439944

http://www.w3.org/2001/XMLSchema#string

Effect of targeted agents on the endocrine response of breast cancer in the neoadjuvant setting: a systematic review.

about

P2860

P2860

Effect of targeted agents on the endocrine response of breast cancer in the neoadjuvant setting: a systematic review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932